LPTX - Leap Therapeutics EPS beats by $0.04 beats on revenue November, 12 2020 07:19 AM Leap Therapeutics Inc. Leap Therapeutics (LPTX): Q3 GAAP EPS of -$0.09 beats by $0.04.Revenue of $0.38M beats by $0.26M.Press Release For further details see: Leap Therapeutics EPS beats by $0.04, beats on revenue